Life Biosciences — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Life Bioscienceslifebiosciences.com in 𝕏Nov 2025SEC filinghigh confidence

Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs.

BiotechHealthtechLongevityBoston, US

David Sinclair(Director)inSharon Rosenzweig-Lipson(Chief Scientific Officer)inMichael Ringel(Chief Operating Officer)inAmit Shashank(Chief Administrative Officer & General Counsel)inAlexander Tristan Edwards(Executive Officer)Mehmood Khan(Executive Officer)in

Board seatDavid SinclairAdam NeumannBracken Darrell· per SEC Form D · $31M raise · filed Apr 2026

Co-investorsAlpha Wave Global Gaingels PHD Ventures The Venture Collective W ventures W Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.